Page 1 of Clinical Trials for SR141716, 46 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
Last Updated: July 31, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder; Obesity; Hypertension; Smoking
2
Completed
Rimonabant to Reduce Alcohol Consumption
Last Updated: June 4, 2010
Condition(s): Healthy; Alcohol Drinking
3
Terminated
Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes
Last Updated: November 7, 2008
Condition(s): Diabetes Mellitus, Type 2
4
Completed
Japanese Dose-Response Study of Rimonabant in Obese Patients
Last Updated: April 6, 2009
Condition(s): Obesity
5
Terminated
Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)
Last Updated: July 17, 2009
Condition(s): Obesity
6
Terminated
Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients
Last Updated: June 16, 2009
Condition(s): Obesity; Weight Loss
7
Terminated
The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition
Last Updated: April 16, 2010
Condition(s): Obesity
8
Recruiting
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Last Updated: January 3, 2011
Condition(s): Prader-willi Syndrome
9
Terminated
Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise
Last Updated: July 17, 2009
Condition(s): Obesity; Diabetes Mellitus Type 2
10
Terminated
Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug
Last Updated: July 17, 2009
Condition(s): Obesity; Diabetes Mellitus Type 2
11
Completed
REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
Last Updated: December 9, 2010
Condition(s): Diabetes Mellitus, Type 2
12
Completed
Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)
Last Updated: April 17, 2009
Condition(s): Obesity
13
Completed
Interaction Between Rimonabant and Cyclosporine and Tacrolimus
Last Updated: June 9, 2008
Condition(s): Renal Transplantation
14
Completed
Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients
Last Updated: April 17, 2009
Condition(s): Obesity
15
Completed
Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation
Last Updated: April 6, 2009
Condition(s): Maintenance of Smoking Cessation
16
Completed
Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients
Last Updated: April 6, 2009
Condition(s): Obesity; Eating Disorders
17
Terminated
A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes
Last Updated: June 12, 2009
Condition(s): Diabetes Mellitus, Type 2
18
Completed
Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch
Last Updated: April 17, 2009
Condition(s): Smoking Cessation
19
Terminated
European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia
Last Updated: December 9, 2010
Condition(s): Obesity; Dyslipidemias
20
Terminated
Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose
Last Updated: January 25, 2011
Condition(s): Obesity

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=SR141716

Page 1 of Clinical Trials for SR141716, 46 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About